Health care technology and its assessment in eight countriesDIANE Publishing, 1995 - 378 pages This background paper is part of a larger study on International Differences in Health Care Technology and Spending, which consists of a series of back- ground papers. International Health Statistics: What the numbers mean for the United States was published in November 1993, and International Comparisons of Administrative Costs in Health Care appeared in September 1994. An additional background paper will report on lessons for the United States from a comparison; of hospital financing and spending in seven countries. |
From inside the book
Results 1-5 of 24
Page 3
... erythropoietin); neonatal intensive care (including extracorporeal membrane oxygenation); and screening for breast cancer. The eight countries are all at similar levels of socioeconomic development. Their populations vary from 8.5 ...
... erythropoietin); neonatal intensive care (including extracorporeal membrane oxygenation); and screening for breast cancer. The eight countries are all at similar levels of socioeconomic development. Their populations vary from 8.5 ...
Page 10
... erythropoietin (EPO), licensed in the United States in June 1989. EPO is a substance produced through biotechnology that stimulates the bone marrow to make red blood cells. The most frequent use of EPO is inpatients on chronic ...
... erythropoietin (EPO), licensed in the United States in June 1989. EPO is a substance produced through biotechnology that stimulates the bone marrow to make red blood cells. The most frequent use of EPO is inpatients on chronic ...
Page 16
... Erythropoietin for End-Stage Renal Failure: A Review,” J. Technology Assessment Health Care 1993. 57. Medic, M., Masaryk, R., Boumphrey, F., M., and Bell, G., “Lumbar Herniated Disk Disease and Canal Stenosis: Prospective Evaluation by ...
... Erythropoietin for End-Stage Renal Failure: A Review,” J. Technology Assessment Health Care 1993. 57. Medic, M., Masaryk, R., Boumphrey, F., M., and Bell, G., “Lumbar Herniated Disk Disease and Canal Stenosis: Prospective Evaluation by ...
Page 38
... erythropoietin (discussed later in the case study on end-stage renal disease), the program was also initially applied to the supply of cy - closporine to patients through public hospitals, with grants of $25.1 million being made to ...
... erythropoietin (discussed later in the case study on end-stage renal disease), the program was also initially applied to the supply of cy - closporine to patients through public hospitals, with grants of $25.1 million being made to ...
Page 48
... Erythropoietin. (EPO). Recombinant EPO for management of anemia due to renal failure has been used in Australia since 1990, initially on a restricted basis because of its cost. It was suggested that treatment might need to be limited to ...
... Erythropoietin. (EPO). Recombinant EPO for management of anemia due to renal failure has been used in Australia since 1990, initially on a restricted basis because of its cost. It was suggested that treatment might need to be limited to ...
Common terms and phrases
activities approval areas Association Australia authorities benefits breast cancer budget CABG Canada centers changes clinical Committee concern considered continued costs Council countries covered Department devices dialysis diffusion disease drugs early economic effective equipment established evaluation experts facilities federal financing France funds guidelines health care health care system health care technology health services hospitals imaging important increase industry Institute introduction issues laparoscopic less limited major Medicare ment million neonatal Netherlands Office operating organizations patients payment percent performed physicians planning population practice problems procedures provincial PTCA recent recommendations regional regulation renal responsibility role scanners scanning screening sickness funds social SOURCE studies surgery Sweden technology assessment tion transplantation treated treatment trials United University women
Popular passages
Page iv - NOTE: OTA appreciates and is grateful for the valuable assistance and thoughtful critiques provided by the advisory panel members. The panel does not, however, necessarily approve, disapprove, or endorse this report. OTA assumes full responsibility for the report and the accuracy of its contents.
Page 17 - What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.
Page 299 - USPSTF is a committee impaneled by the Office of Disease Prevention and Health Promotion (in the Department of Health and Human Services) that produced a set of 169 recommended preventive services, collected and published as a book in 1989 (154).
Page 242 - For mental illness: • to improve significantly the health and social functioning of mentally ill people, • to reduce the overall suicide rate by at least 15 percent by the year 2000...
Page 18 - Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery
Page 270 - Impact of the NHS Reforms The NHS reforms at present have not affected the screening service in any major way. At present, the funding for breast screening and the centralized style of service provision have been protected, but this will not necessarily continue to be the case. Breast screening has been given" additional impetus by virtue of its inclusion in the national health strategy. The proposed target is to reduce the death rate for breast cancer in the population invited for screening by at...
Page 97 - Canadian Erythropoietin Study Group, "Association Between Recombinant Human Erythropoietin and Quality of Life and Exercise Capacity of Patients Receiving Haemodialysis,
Page 299 - Sciences NIH National Institutes of Health NIMH National Institute of Mental Health NINDS National Institute of Neurological Disorders and Stroke...
Page 60 - Worldwide Differences in Asthma Prevalence and Mortality. Why is Asthma Mortality So Low in the USA?
Page 15 - Magnetic Resonance Imaging of the Brain and Spine. Is Clinical Efficacy Established After the First Decade,